Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dorval

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?A C Braud, B Asselain, S Scholl, et al.
Anticancer Research|January 1, 1982
Treatment of lymphoid neoplasias with interferon. II. Human leucocyte alpha-interferon in chronic lymphatic leukemia (CLL). PHase I-II trialJ L Misset, G Mathé, J Gastiaburu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional studyE Tartour, J Y Blay, T Dorval, et al.
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.
Journal of Neuro-Oncology|September 18, 2013
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepaA Comte, W Jdid, M N Guilhaume, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 familyF A Montero-Julian, H Brailly, C Sautès, et al.
Journal Francais D'Ophtalmologie|September 22, 2006
[Prognostic factors for malignant uveal melanoma. Retrospective study on 2,241 patients and recent contribution of monosomy-3 research]L Desjardins, C Levy-Gabriel, L Lumbroso-Lerouic, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2009
Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut CurieP Mariani, S Piperno-Neumann, V Servois, et al.
Clinical and Experimental Immunology|December 22, 1999
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patientsN Haicheur, B Escudier, T Dorval, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?A C Braud, B Asselain, S Scholl, et al.
Anticancer Research|January 1, 1982
Treatment of lymphoid neoplasias with interferon. II. Human leucocyte alpha-interferon in chronic lymphatic leukemia (CLL). PHase I-II trialJ L Misset, G Mathé, J Gastiaburu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional studyE Tartour, J Y Blay, T Dorval, et al.
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.
Journal of Neuro-Oncology|September 18, 2013
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepaA Comte, W Jdid, M N Guilhaume, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 familyF A Montero-Julian, H Brailly, C Sautès, et al.
Journal Francais D'Ophtalmologie|September 22, 2006
[Prognostic factors for malignant uveal melanoma. Retrospective study on 2,241 patients and recent contribution of monosomy-3 research]L Desjardins, C Levy-Gabriel, L Lumbroso-Lerouic, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2009
Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut CurieP Mariani, S Piperno-Neumann, V Servois, et al.
Clinical and Experimental Immunology|December 22, 1999
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patientsN Haicheur, B Escudier, T Dorval, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.
Pageof 11